Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma 6Leukemia 6Myelodysplastic Syndromes 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Primary Myelofibrosis 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Lymphoma, Non-Hodgkin 3Kidney Neoplasms 3Hodgkin Disease 3Wilms Tumor 2Thrombocythemia, Essential 2Rhabdomyosarcoma 2Recurrence 2Polycythemia Vera 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Neoplasms 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2Graft vs Host Disease 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Thrombocytopenia 1Testicular Neoplasms 1

Interventions

Rituximab 4Cyclophosphamide 4Etoposide 3Dexamethasone 3ponatinib 2pomalidomide 2fludarabine 2Whole-Body Irradiation 2Vincristine 2Sirolimus 2Prednisone 2Platelet Transfusion 2Mycophenolic Acid 2Lenalidomide 2Ifosfamide 2Doxorubicin 2Carboplatin 2Busulfan 2Brentuximab Vedotin 2Alemtuzumab 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2ricolinostat 1pembrolizumab 1nilotinib 1ibrutinib 1fludarabine phosphate 1epratuzumab 1daratumumab 1dacetuzumab 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hematologic Diseases × Stem Cell Transplantation × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡